Liquidia (LQDA) Cash & Current Investments (2019 - 2026)
Liquidia (LQDA) posted Cash & Current Investments of $284.2 million for Q2 2026, up 27.56% on a QoQ basis from $222.8 million in Q1 2026, and up 63.87% year-over-year from $173.4 million in Q2 2025.
Analysis
Liquidia (LQDA) Cash & Current Investments (2019 - 2026) Analysis & Trends
Liquidia has reported Cash & Current Investments for 8 years, with the latest figure at $284.2 million in Q2 2026.
- On a quarterly basis, Cash & Current Investments rose 63.87% year-over-year to $284.2 million in Q2 2026; TTM through Jun 2026 was $284.2 million, a 63.87% increase from a year earlier, with the FY2025 full-year figure at $190.7 million, up 8.05% from the prior year.
- Cash & Current Investments was $284.2 million for Q2 2026 at Liquidia, up from $222.8 million in the prior quarter.
- The five-year high for Cash & Current Investments was $284.2 million in Q2 2026, with the low at $57.8 million in Q1 2022.
- Average Cash & Current Investments over 5 years is $142.5 million, with a median of $145.3 million recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments jumped 168.11% in 2024, then slipped 22.94% in 2025.
- Over 5 years, Cash & Current Investments stood at $93.3 million in 2022, then declined by 10.3% to $83.7 million in 2023, then jumped by 110.9% to $176.5 million in 2024, then climbed by 8.05% to $190.7 million in 2025, then jumped by 49.04% to $284.2 million in 2026.
- The last three Cash & Current Investments figures came in at $284.2 million (Q2 2026), $222.8 million (Q1 2026), and $190.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 20.76 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 7.14 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 7.69 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 11.70 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 7.38 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 4.54 Bn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 2.66 Bn |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | 284.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 284.18 Mn |
| Mar 31, 2026 | 222.79 Mn |
| Dec 31, 2025 | 190.68 Mn |
| Sep 30, 2025 | 157.50 Mn |
| Jun 30, 2025 | 173.42 Mn |
| Mar 31, 2025 | 169.76 Mn |
| Dec 31, 2024 | 176.48 Mn |
| Sep 30, 2024 | 204.37 Mn |
| Jun 30, 2024 | 133.09 Mn |
| Mar 31, 2024 | 157.86 Mn |
| Dec 31, 2023 | 83.68 Mn |
| Sep 30, 2023 | 76.23 Mn |
| Jun 30, 2023 | 88.20 Mn |
| Mar 31, 2023 | 94.41 Mn |
| Dec 31, 2022 | 93.28 Mn |
| Sep 30, 2022 | 98.32 Mn |
| Jun 30, 2022 | 103.84 Mn |
| Mar 31, 2022 | 57.80 Mn |
| Dec 31, 2021 | 57.49 Mn |
| Sep 30, 2021 | 64.10 Mn |